BBB National Programs Decision Summaries
BBB National Programs provides summaries of all case decisions from the National Advertising Division (NAD), National Advertising Review Board (NARB), Children’s Advertising Review Unit (CARU), Direct Selling Self-Regulatory Council (DSSRC), and Digital Advertising Accountability Program (DAAP). Subscribe to receive a weekly wrap-up of published case decisions in your inbox.
- All
-
1/25/2018 - NAD Recommends Chattem Discontinue ‘Smart’ Design, Formulation Claims for Xyzal Allergy Medication
The National Advertising Division has recommended that Chattem, Inc., the maker of Xyzal Allergy 24HR medication, discontinue claims that convey the message that the product’s “smart” or “wise” design confers a clinically meaningful benefit compared to Johnson & Johnson Consumer Inc.’s Zyrtec. -
1/16/2018 - NAD Refers StubHub Pricing Claims to FTC for Further Review After Advertiser Declines to Comply with NAD Decision on Disclosures
The National Advertising Division has referred pricing claims made at StubHub.com, an online ticket exchange, to the Federal Trade Commission (FTC) after the company declined to comply with NAD’s recommendations to more clearly disclose the additional taxes and fees applied to each ticket purchase. -
1/11/2018 - NAD Recommends Cebria Discontinue Challenged Claims for Dietary Supplement Promoted as a Memory Protection Aid; Company to Appeal
The National Advertising Division has recommended that Cebria, the maker of Cebria dietary supplement, discontinue certain claims challenged by the Council for Responsible Nutrition, including broad and unqualified memory improvement claims. -
1/10/2018 - NAD Finds GSK Can Support Certain Claims for Citrucel, Recommends Company Modify, Discontinue Certain Claims After P&G Successfully Petitions NAD to Re-Open 1994 Case
The National Advertising Division has determined that GSK Consumer Health can support certain claims for its Citrucel laxative product, but recommended that the company modify or discontinue certain claims, re-opening a matter heard by NAD in 1994. -
1/09/2018 - NAD Refers Advertising for ‘Fungi-Nail’ Products to FTC for Further Review After Company Declines to Comply with NAD Recommendations
The National Advertising Division has referred advertising claims made by Kramer Laboratories, Inc. to the Federal Trade Commission and Food and Drug Administration for further review after the company said it would not comply with NAD’s recommendation to change the name The Original Fungi-Nail Toe & Foot Brand product. -
1/08/2018 - NAD Recommends Dr. Harold Katz Discontinue Health-Performance Claims for Therabreath Rinse, Lozenges; Company to Appeal
The National Advertising Division has recommended Dr. Harold Katz, LLC, discontinue certain advertising claims for the company’s Therabreath Dry Mouth Treatment products, including claims that the products “relieve” or “fight” dry mouth symptoms. The company said it will appeal NAD’s adverse findings to the National Advertising Review Board. -
1/03/2018 - NAD Recommends SCA Personal Care Discontinue ‘Zero Leaks’ Claims for TENA Overnight Adult Underwear Following Challenge by Kimberly-Clark
The National Advertising Division has recommended that SCA Personal Care, Inc., discontinue claims that consumers will experience “zero leaks” when wearing the company’s TENA Overnight adult incontinence underwear. -
12/14/2017 - Eufy Says It Has Permanently Discontinued Claims for Robotic Vacuum Challenged by iRobot
Eufy, the maker of the RoboVac 11 Model T2101 robotic vacuum cleaner, has said it will discontinue all advertising claims challenged by iRobot Corporation before the National Advertising Division. iRobot challenged claims made by Eufy at its website and at Amazon. -
12/14/2017 - NAD Recommends Alcon Laboratories Discontinue Certain Claims for ‘Clear Care’ Products, Including Certain ‘Natural Tears’ Claims
The National Advertising Division has recommended Alcon Laboratories, Inc. discontinue claims that because they are preservative-free, the company’s Clear Care and Clear Care Plus contact lens solutions are “more like natural tears.” The claims were challenged by Bausch & Lomb, a competing maker of products for contact-lens patients. -
12/13/2017 - NAD Finds Church & Dwight Can Support Certain Claims for ‘Slide’ Cat Litter; Recommends Company Modify, Discontinue Demonstration
The National Advertising Division has determined that Church & Dwight Co., Inc., provided a reasonable basis for stand-alone performance claims made in product packaging, website, and broadcast advertising for the company’s Arm & Hammer Slide Cat Litter. NAD recommended the advertiser modify or discontinue the comparative product demonstration featured in the television and website advertising.